Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Curcumin Formulation (Longvida) or Placebo on Plasma Biomarkers and Mental State in Moderate to Severe Alzheimer's Disease or Normal Cognition

NCT01001637 is registered in ClinicalTrials.gov with Jaslok Hospital and Research Centre as lead sponsor.

NCT NCT01001637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01001637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Curcumin Formulation (Longvida) or Placebo on Plasma Biomarkers and Mental State in Moderate to Severe Alzheimer's Disease or Normal Cognition
Lead sponsor
Jaslok Hospital and Research Centre
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2009
Completion date
November 30, 2010
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease